Page last updated: 2024-10-27

fenofibrate and Polycystic Ovary Syndrome

fenofibrate has been researched along with Polycystic Ovary Syndrome in 2 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.

Research Excerpts

ExcerptRelevanceReference
"Letrozole-treated rats showed successful induction of PCOS, confirmed by histopathology and significantly increased body weight, testosterone, insulin, AMH, and MDA, and decreased SOD."4.12Fenofibrate ameliorates letrozole-induced polycystic ovary in rats via modulation of PPARα and TNFα/CD95 pathway. ( El-Hussieny, M; Morsy, MA; Nair, AB; Refaie, MMM; Venugopala, KN; Zenhom, NM, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Miao, C1
Chen, Y1
Fang, X1
Zhao, Y1
Wang, R1
Zhang, Q1
Morsy, MA1
El-Hussieny, M1
Zenhom, NM1
Nair, AB1
Venugopala, KN1
Refaie, MMM1

Other Studies

2 other studies available for fenofibrate and Polycystic Ovary Syndrome

ArticleYear
Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Computational Biology; Endometrial Neoplasms; Female; Fenofibrate; Gene Regulatory Networks; Humans;

2022
Fenofibrate ameliorates letrozole-induced polycystic ovary in rats via modulation of PPARα and TNFα/CD95 pathway.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:20

    Topics: Animals; Anti-Mullerian Hormone; Body Weight; Disease Models, Animal; Female; Fenofibrate; Humans; I

2022